ANDREA LEE VEATCH MD NPI 1952398158

NPI Details

Andrea Lee Veatch, MD is a hematology and oncology internal medicine in Puyallup, WA with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Andrea Lee Veatch, MD NPI is 1952398158. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Graduation Year:1995

The provider's business location address is:

2920 SOUTH MERIDIAN
SUITE 100
PUYALLUP, WA
ZIP 98373-428
Phone: (253) 841-4296
Fax: (253) 841-2435

The NPI 1952398158 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Bilirubin level, direct (HCPCS:82248)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Unclassified drugs (HCPCS:J3490)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Magnesium level (HCPCS:83735)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Folic acid level, serum (HCPCS:82746)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Uric acid level, blood (HCPCS:84550)
• Collection of blood sample from implanted device (HCPCS:36591)
• Red blood count automated, with additional calculations (HCPCS:85046)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Declotting of central venous tube (HCPCS:36593)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)

The enumeration date for this NPI number is 10/3/2005 and was last updated on 11/22/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.